✦ LIBER ✦

Charlson's index: A validation study to predict surgical adverse events in gynecologic oncology

✍ Scribed by S. Kondalsamy-Chennakesavan; S. Johnson; J. Nicklin; R. Land; A. Garrett; A. Obermair

Book ID: 113963014
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 52 KB
Volume: 120
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2010.12.291

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Application of a risk scoring system to

Application of a risk scoring system to predict surgical adverse events in the management of epithelial ovarian cancers

✍ Andrew John Li 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Pathologic models to predict outcome for

Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage--A gynecologic oncology group study

✍ Richard J. Zaino; Robert J. Kurman; Karen L. Diana; C. Paul Morrow 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Numerous pathologic factors have heen identified as important in predicting outcome for women with endometrial adenocarcinoma. However, most patients have a mixture of good and bad factors. For these women, the prognosis is uncertain, and it is often unclear whether postoperative therapy is indicate

Echocardiography to predict adverse card

Echocardiography to predict adverse cardiac and vascular events in patients with severe chronic kidney disease (stage 4): A prospective study

✍ Lesaffre, François; Wynckel, Alain; Nazeyrollas, Pierre; Rieu, Philippe; Metz, D 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 308 KB

Pathologic models to predict outcome for

Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage—A Gynecologic Oncology Group study. Cancer 1996; 77:1115–21

📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Negative survival impact associated with

Negative survival impact associated with >25 day interval from surgical cytoreduction to initiation of systemic therapy in advanced ovarian carci- noma: A Gynecologic Oncology Group ancillary data study

✍ Eskander, R.; Java, J.; Tewari, K.; Burger, R.; Monk, B. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 291 KB

Prospective investigation of risk factor

Prospective investigation of risk factors for gastrointestinal adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer: A Gynecologic Oncology Group study

✍ R. Burger; M. Brady; M. Bookman; B. Monk; J. Walker; H. Homesley; J. Fowler; B. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 55 KB